| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | 0.079 | 0.02 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.03 |
| mRNA | Salubrinal | GDSC1000 | pan-cancer | AAC | 0.12 | 0.03 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | 0.077 | 0.03 |
| mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | -0.069 | 0.03 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | 0.085 | 0.03 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | -0.065 | 0.03 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | -0.082 | 0.03 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | -0.075 | 0.03 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.074 | 0.03 |